HCW Biologics Inc (HCWB) Live Share Price, Invest From India

HCW Biologics Inc Stock Performance

as on May 21, 2026 at 5:14 am IST

Day's Low
Day's High
$1.06
Day's Price Range
$3.99
$2.66
60.15%
Downside
50.00%
Upside
52 Week's Low
52 Week's High
$0.25
52-Week Price Range
$9.33
$2.66
90.60%
Downside
250.75%
Upside

HCW Biologics Inc share price movements today

Previous Close: $1.06
Open: $1.08
Volume: 236.4M
Day's Low - High: $1.06 - $3.99
52 Week Low - High: $0.25 - $9.33

HCW Biologics Inc Historical Returns

1 Month Return: + 157.91 %
3 Month Return: + 83.07 %
1 Year Return: -88.45 %
3 Year Return: -98.2 %
5 Year Return: 0 %

HCW Biologics Inc Stock Fundamentals & Key Indicators

Check HCW Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.0M

EPS (TTM)

-0.96

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-7.7M

Revenue (TTM)

6.6M

Profit Margin

-34.74%

Return On Equity TTM

-27725.96%

HCW Biologics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of HCW Biologics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
HCW Biologics Inc	BUY	$9.0M	NA	NA	-34.74%
Alnylam Pharmaceuticals Inc	BUY	$38.2B	110.06%	71.93	12.55%
Vertex Pharmaceuticals Inc	BUY	$110.8B	100.5%	25.91	35.51%
Regeneron Pharmaceuticals Inc	BUY	$66.0B	22.82%	15.38	29.65%

Stock Returns calculator for HCW Biologics Inc Stock including INR - Dollar returns

The HCW Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

HCW Biologics Inc investment value today

Current value as on today

₹32,794

Returns

-₹67,206

(-67.21%)

Returns from HCW Biologics Inc Stock

-₹71,024 (-71.02%)

Dollar Impact

₹3,818 (+3.82%)

Analyst Recommendation on HCW Biologics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for HCW Biologics Inc. Average target price of $2

HCW Biologics Inc Share Price Target

Get share price movements and forecasts by analysts on HCW Biologics Inc.

What analysts predicted

-33%DOWNSIDE

Target Price

Current Price

$2.66

Analyzed by

8 Analysts

Target

$2.00

HCW Biologics Inc target price $2, a slight downside of -33% compared to current price of $2.66. According to 8 analysts rating.

Indian Investors' Interest in HCW Biologics Inc Stock

Investment in HCW Biologics Inc Shares on INDmoney has grown by 514.58% in the last 30 days, indicating increased investment activity.

Time period: April 20, 2026 to May 20, 2026

Change:514.58% versus previous 30 day period

Search interest for HCW Biologics Inc Stock has increased by 223% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 20, 2026 to May 20, 2026

Change:223% versus previous 30 day period

HCW Biologics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	1	1	0	0	0	0	0	0	0	6
Gross Profit	0	0	0	0	0	0	0	0	0	6
Operating Income	-10	-7	-15	-3	-3	-1	-3	-3	-2	3
EBITDA	-	-7	-14	-3	-1	-1	-1	-4	1	3
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-10	-7	-15	-3	-3	-2	-1	-4	0	3
Income Tax Expense	-	0	0	-	-	-	-	-	-	0
Net Income	-10	-7	-15	-3	-3	-2	-1	-4	0	4
Net Profit Margin	-806.69%	-662.82%	-2469.11%	-915.12%	-854.42%	-43373.64%	-29430.99%	-29183.24%	2662.84%	63.16%

HCW Biologics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	4	4	6	2	2	0
Gross Profit	0	4	0	2	0	0	0
Operating Income	-7	-5	-13	-15	-25	-29	-11
EBITDA	-6	-5	-12	-14	-23	-27	-5
Interest Expense	-	-	0	0	0	1	1
Depreciation	0	0	0	0	1	1	1
Income Before Tax	-7	-5	-12	-14	-24	-30	-7
Income Tax Expense	0	0	0	0	0	-	-
Net Income	-7	-5	-12	-14	-24	-30	-7
Net Profit Margin	0.00%	-140.98%	-313.74%	-221.67%	-879.52%	-1169.70%	-14677.14%

HCW Biologics Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-7	-15	-3	-3	-2	-1	-4	0	3
Operating Cash Flow	-3	-4	-2	-2	-3	-3	-3	-3	-1
Investing Cash Flow	0	0	0	0	-	-	-	-	-
Financing Cash Flow	4	1	2	6	0	4	1	4	0
Change in Cash	0	-2	0	3	-3	1	-1	0	0

HCW Biologics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-12	-14	-24	-30	-7
Operating Cash Flow	-10	-10	-10	-22	-14	-13
Investing Cash Flow	0	-35	14	3	0	-
Financing Cash Flow	11	49	6	0	15	10
Change in Cash	1	3	10	-18	1	-2

Global Institutional Holdings in HCW Biologics Inc

Funds	Holdings
Bank of America Corp	0%
Susquehanna International Group, LLP	0.3%
UBS Group AG	0%
Vanguard Group Inc	0.23%
Geode Capital Management, LLC	0.21%

See all

Insights on HCW Biologics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -4.55M → 4.13M (in $), with an average increase of 407.9% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 5 quarters, 5.06K → 6.54M (in $), with an average increase of 55.6% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, HCWB stock has moved up by 203.4%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 2.5% return, outperforming this stock by 91.0%
NO EFFECT
Against Peers
In the last 3 years, HCW Biologics Inc. Common Stock has experienced a drawdown of -98.2%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 81.2%

About HCW Biologics Inc

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for alopecia areata diseases. The company also develops HCW9201, a fusion protein designed as a reagent to use in the production of natural killer (NK) cell-based therapies; HCW9206, a fusion protein designed as a reagent to use in the production of CAR-therapies for the treatment of infectious diseases; and HCW11-006, an immune cell stimulator. It has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

Organisation	HCW Biologics Inc
Headquarters	2929 North Commerce Parkway, Miramar, FL, United States, 33025
Industry	Biotechnology
CEO	Dr. Hing C. Wong Ph.D.
E-voting on shares	Click here to vote

Key Management of HCW Biologics Inc

Name	Title
Ms. Nicole Valdivieso Esq., J.D.	Vice President of Legal Affairs
Mr. Lee D. Flowers	Senior Vice President of Business Development
Dr. Hing C. Wong Ph.D.	Founder, CEO, Director & Secretary
Ms. Rebecca Byam CPA, M.B.A.	Chief Financial Officer
Dr. Peter Rhode Ph.D.	Chief Scientific Officer & VP of Clinical Operations

FAQs

What is HCW Biologics Inc share price today?

HCW Biologics Inc share price today is $2.66 as on May 20, 2026 at 11:44 pm IST. HCW Biologics Inc share today touched a day high of $3.99 and a low of $1.06.

What is the 52 week high and 52 week low for HCW Biologics Inc share?

HCW Biologics Inc share touched a 52 week high of $9.33 on May 20, 2025 and a 52 week low of $0.25 on April 2, 2026. HCW Biologics Inc stock price today i.e. May 20, 2026 at 11:44 pm IST is trending at $2.66,which is 71.49% down from its 52 week high and 964.00% up from its 52 week low.

What is HCW Biologics Inc's market capitalisation today?

HCW Biologics Inc market capitalisation is $0.00T as on May 20, 2026 at 11:44 pm IST.

How to invest in HCW Biologics Inc Stock (HCWB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for HCW Biologics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in HCW Biologics Inc Shares that will get you 0.5639 shares as per HCW Biologics Inc share price of $2.66 per share as on May 20, 2026 at 11:44 pm IST.

What is the minimum amount required to buy HCW Biologics Inc Stock (HCWB) from India?

Indian investors can start investing in HCW Biologics Inc (HCWB) shares with as little as ₹96.81 or $1 (as of May 20, 2026 at 11:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹968.10 in HCW Biologics Inc stock (as per the Rupee-Dollar exchange rate as on May 20, 2026 at 11:44 pm IST). Based on HCW Biologics Inc share’s latest price of $2.66 as on May 20, 2026 at 11:44 pm IST, you will get 3.7594 shares of HCW Biologics Inc. Learn more about fractional shares .